All News

After being declared cancer-free, Ed found himself back in the doctor's office again.

Eunice Wang, M.D., discusses a promising new drug for the treatment of certain patients with acute myeloid leukemia.

In an interview with CURE, Badani, a professor of Urology at Mount Sinai Hospital, discusses the benefits of robotic surgery in RCC.

Try not to let cancer hinder your career.

Two-time cancer survivor offers help for fatigue, including fatigue that is months and years out from active treatment

Living in fear and worrying about cancer every day is not a way to live. I was given six amazing words of advice that were my wakeup call to get my life after cancer back.

Help us figure out the best, most respectful words to use when discussing cancer.

"I don't think I could breathe without him," said one patient on CURE's Facebook page. See how four-legged friends helped others through their cancer experience.

The treatment paradigm for patients with advanced non-small cell lung cancer (NSCLC) is changing, as more emphasis is being placed on drug combinations and biomarkers, says Roy S. Herbst, M.D., Ph.D.

Cancer treatment may seem to involve a mysterious, unfathomable foreign language, but there are ways to improve those lines of communication.

Sometimes powerful, sometimes painful, there are lessons in cancer at every turn.

The designation recognizes that the vaccine, an immunotherapy called SurVaxM, would treat a rare disease, defined as one that affects a patient population of less than 200,000 Americans. However, because it acts on a protein that appears in 80 percent of cancers generally, SurVaxM may have wider applications.

A type of CAR-T cell therapy is showing promise in a phase 1 study for patients with Hodgkin lymphoma and ALCL.

Researchers at Yale compared people who used conventional therapy to those who used only alternative methods

A breast cancer survivor learns to shed her old identity and adapt to her new one.

Appreciating the benefits of radiation, but still hoping for better advancements in an evolving field.

Lynparza tablets (olaparib) tablets were granted FDA approval as a maintenance therapy for patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer, who are in a complete or partial response to platinum-based chemotherapy.

Besponsa (inotuzumab ozogamicin) was granted FDA approval for certain patients with ALL.

This disconnect can lead to increased burden for caregivers. Researchers from City of Hope National Medical Center in Duarte, California, found that patients view themselves as being more able than their caregivers thought.

It's time to start paying attention to what comes after cancer treatment.

My little yellow dog helped me through cancer and over a year after her death, I still love and miss her--Barbara Tako

Driven by personal experience and his love for art, Ryan Berardi created a 3D animation that would help health care professionals if they wrongly administer chemotherapy to patients.

ASCO updated guidelines for the treatment of certain patients with advanced non-small cell lung cancer (NSCLC).

We are never prepared to hear the words, "You have cancer."

Patient-centered care is about more than you may think!

CRISPR technology may one day lead the field in turning off genetic mutations that cause numerous diseases, such as lung cancer. CURE spoke with Monte Winslow, Ph.D., about CRISPR's current use in mouse models.

A new agent showed a favorable toxicity profile for patients with epithelial ovarian cancer. The drug, mirvetuximab soravtansine (IMGN853), also demonstrated encouraging clinical activity in a phase 1 trial presented at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting.

Survivors tend to find ways to trick themselves into feeling better, from “Look Good Feel Better” to prayer. Singing in the shower (or bathtub) has helped me. What strategies have you designed?